Cargando…
HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center
BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a severe or even fatal inflammatory state. Epstein–Barr virus (EBV) infection-associated HLH (EBV-HLH) is one of the most common secondary HLH and suffers a very poor prognosis. Allo-HSCT is often required for refractory EBV-HLH, but some patie...
Autores principales: | Song, Yue, Wang, Jingshi, Wang, Yini, Wang, Zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329501/ https://www.ncbi.nlm.nih.gov/pubmed/32611452 http://dx.doi.org/10.1186/s13287-020-01779-4 |
Ejemplares similares
-
PEG-aspargase and DEP regimen combination therapy for refractory Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis
por: Wang, Jingshi, et al.
Publicado: (2016) -
Epstein–Barr Virus and Hemophagocytic Lymphohistiocytosis
por: Marsh, Rebecca A.
Publicado: (2018) -
Epstein-Barr Virus-Induced Hemophagocytic Lymphohistiocytosis
por: Goudarzipour, K., et al.
Publicado: (2013) -
Development of a Nomogram to Predict the Risk of Chronic Active Epstein-Barr Virus Infection Progressing to Hemophagocytic Lymphohistiocytosis
por: He, Xiaodan, et al.
Publicado: (2022) -
Epstein–Barr virus infection–Related hemophagocytic lymphohistiocytosis
por: Kumar, Navin, et al.
Publicado: (2015)